Today's Spotlight

The Changing Landscape of Glaucoma Therapy

When evaluating options for glaucoma management, the number of treatments is growing and changing at a pace that is faster than ever. Historically, optometrists have had a relatively limited number of choices for their glaucoma patients, not only in terms of topical medications but also surgical interventions. There are changes on the horizon, as, now more than ever, practitioners have a fairly large number of topical medications in their arsenal, with even more on the way.
Today's Spotlight

Dry Eye Drugs: New Approaches to an Old Problem

Although DED is widely encountered in eye care practices, the number of pharmaceutical agents available to combat it pales in comparison with other chronic diseases.1-3 Fortunately, new and upcoming dry eye medications may change the landscape of DED management for the better. Here is a comprehensive look at new dry eye drugs and a preview of treatment options of the future. 
Today's Spotlight

Glaucoma Tools: Know the New Codes

Diagnostic testing for glaucoma suspects never seems to stagnate. Significant changes that apply to recent technologies became effective on January 1, and they may affect how you approach your glaucoma workup.

Today's Spotlight

RPE: The Multitasking Master

The retinal pigmented epithelium (RPE) is composed of a hexagonal monolayer of epithelial cells. Despite its structural simplicity, the RPE plays an essential role in many cellular processes necessary for visual function. Both the RPE’s location within the retina and its cellular characteristics directly correlate with its functions, and a breakdown of these processes is implicated in many retinal diseases.

Today's Spotlight

Don’t Bet on Red

I have a new spectral-domain optical coherence tomographer (SD-OCT) that I used to perform an optic nerve evaluation on a patient. The test shows a very thin nerve fiber layer (NFL) and ganglion cell layer thinning. The patient has para-nasal visual field defects in both eyes. Her discs look normal, her IOP is 15mm HG OU and there is no family history of glaucoma. Is this low-tension glaucoma?  

Mar 22
Mar 21
Mar 20
Mar 19
Mar 18

The News Feed

Look Inside The Current Issue

March 15, 2019

Features

Anti-VEGF: Where Are We Now?

This review looks into the years of research on this versatile class of medications and turns an eye to its future.

Can You Spot These Retinal Vascular Abnormalities?

Abnormal changes in the retinal vasculature are closely linked with underlying systemic conditions—impacting both the physical and ocular health of the patient.

Dry Eye Drugs: New Approaches to an Old Problem

Its multifactoral and variable nature makes DED a challenging condition to manage. These novel therapeutics are here to help.

My Patient Has Glaucoma...Now What?

After a clinical examination and testing, your diagnosis is confirmed. Now, it’s time to develop a management plan. Here’s how.

Red Eye Roundup

This symptom could be a harbinger of many conditions. Here’s a look at the common causes and what to do about them.

The Changing Landscape of Glaucoma Therapy

The future looks promising with the recent introduction of new treatment options.

Departments

A Diagnosis for the Birds

How can this patient’s presentation and MRI explain his vision loss?

A Stroke of Bad Luck

By the time you see this, it may be too late to save vision, but your responsibility doesn’t end there.

Beware the Red Herring LEMS

Lambert-Eaton myasthenic syndrome may present similarly to other neurological diseases.

CMV: Old Foe, New Victims

Immunocompromised patients aren’t the only ones at risk from cytomegalovirus.

Don’t Bet on Red

Know how to use OCT data to decide whether a patient truly has glaucoma.

Glaucoma Tools: Know the New Codes

Increased use of new diagnostic technology led to changes that impact your workup.

In Between Days

The defeat of the Arkansas expansion bill is more a delay of the inevitable rather than an outright failure.

Let the Truth Set You Free

Quit worrying about number one or number two. We have bigger truths to face, like that golf shirt you are wearing.

New Meds: Today and Tomorrow

Our pharmaceutical toolbox is practically bursting at the seams these days.

RPE: The Multitasking Master

This simple structure is crucial for maintaining visual function in more ways than one.

The Skinny on Peculiar Skin

A 67-year-old black female reported to the office with a chief complaint of blurry vision at near, as well as facial skin lesions. She asked if there was any medication that could improve her skin cosmesis.

Twice the Conditions, Twice the Fun

While the presence of other corneal abnormalities makes things difficult for this keratoconus patient, CXL should be initiated as soon as disease progression is detected.

E-Newsletters

Practice Pearls

Expert clinician Paul Karpecki, OD, provides practical insights and management strategies for a wide array of ocular conditions.

Optometric Retina Society E-Newsletter

Keep up to date on the latest research and clinical findings in retinal disease care with this quarterly publication from the ORS.

Optometric Physician E-Journal

A weekly e-journal edited by Art Epstein, OD, featuring incisive commentary, timely research summaries and late-breaking news.

Continuing Education

Jobs

Jobs Powered By Local Eye Site

Review of Cornea & Contact Lenses

March/April 2019

Women in Optometry

Women in Optometry - November 2018